Palomar Medical: No Change in Bullish Outlook

A New York presenter remains just as bullish on Palomar's prospects as he was two months ago when he presented the name at one of our small cap idea forums (NASDAQ: PMTI, $14.07). He noted then that the stock had a very big and fast run up and would likely take a breather to offer an even better entry point. PMTI has dropped substantially from the $16 level, as he predicted. The presenter argues that it's a 2-3 year story that has the potential to work well enough to double the stock price over that time.